España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Bioage Labs
BIOA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Bioage Labs (BIOA) Forecast
News
Earnings
Bioage Labs (BIOA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Bioage Labs (NASDAQ:BIOA) Stock
Bioage Labs Stock (NASDAQ: BIOA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
BioAge Labs shares are trading higher after t...
Benzinga Newsdesk
BioAge Labs Announces Multi-Year Collaboratio...
Benzinga Newsdesk
Monday, December 09, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Crude Oil Gains 2%; BioAge Labs Shares Plunge
Avi Kapoor
Nasdaq Down Over 100 Points; US Wholesale Inventories Rise By 0.2%
Avi Kapoor
Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
BioAdge Labs shares are trading lower after J...
Benzinga Newsdesk
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
Vandana Singh
Citigroup Downgrades Bioage Labs to Neutral, ...
Benzinga Newsdesk
Jefferies Downgrades Bioage Labs to Hold, Low...
Benzinga Newsdesk
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, December 06, 2024
Trading Halt: Halt status updated at 4:55:00 ...
Benzinga Newsdesk
BioAge Labs Discontinues STRIDES Phase 2 Tria...
Benzinga Newsdesk
Trading Halt: Halted at 4:00:10 p.m. ET - Tra...
Benzinga Newsdesk
Monday, November 04, 2024
BioAge Labs shares are trading higher after t...
Benzinga Newsdesk
BioAge Labs To Present New Preclinical Data F...
Benzinga Newsdesk
CORRECTION: Bioage Labs Ticker Is "BIOA"
Benzinga Newsdesk
Monday, October 21, 2024
BioAge Labs shares are trading higher after m...
Benzinga Newsdesk
Citigroup Initiates Coverage On Bioage Labs w...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Bioage L...
Benzinga Newsdesk
Jefferies Initiates Coverage On Bioage Labs w...
Benzinga Newsdesk
Thursday, September 26, 2024
Bioage Labs Shares Open For Trade At $22.50/S...
Benzinga Newsdesk
Bioage Labs IPO Indicating $34.97/Share On 10...
Benzinga Newsdesk
Bioage Labs IPO Indicating $36/Share On 86,77...
Benzinga Newsdesk
Trading Halt: Halt status updated at 10:10:00...
Benzinga Newsdesk
Reported Earlier, BioAge Labs Announced The P...
Benzinga Newsdesk
Wednesday, September 25, 2024
Bioage Labs, Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights
Tuesday, May 08, 2018
H.C. Wainwright Place BioAmber 'Buy' Rating U...
Benzinga
Friday, February 16, 2018
BioAmber Shares Down 4.8%; Earlier Co. Receiv...
Benzinga
Earlier 13G Filing Shows Sabby Management Rep...
Benzinga
Thursday, February 15, 2018
BioAmber Shares Down 9.8%, Continuing To Drop...
Benzinga
Tuesday, February 13, 2018
BioAmber Receives Deslisting Notice From Toro...
Benzinga
Friday, February 09, 2018
BioAmber Inc. Announces Registered Direct Offering; Termination of Underwriting Agreement for Previously-Announced Public Offering; Will Purchase 46.67M Series A Units
Benzinga
BioAmber Reports 46.67M Series A Units Regist...
Benzinga
Thursday, February 08, 2018
BioAmber Shares Halted, News Pending
Benzinga
Tuesday, February 06, 2018
BioAmber Shares Down 50% As Co. Prices $10M P...
Benzinga
BioAmber Prices 40M Series A Units At $0.25/S...
Benzinga
Monday, February 05, 2018
BioAmber Reports Commencement Of Offering For...
Benzinga
Monday, January 29, 2018
BioAmber Shares Up 19.85% Premarket After Rep...
Benzinga
BioAmber Says Bio-Succinic Acid Demonstrates ...
Benzinga
Tuesday, November 07, 2017
BioAmber Reports Q3 Adj. EPS $(0.21) vs $(0.2...
Benzinga
Tuesday, October 24, 2017
BioAmber Reports Pres, COO Fabrice Orecchioni...
Benzinga
Monday, October 09, 2017
The Week Ahead: New IPOs, Bank Earnings, And Some Notable FDA Actions
Benzinga
Thursday, September 14, 2017
BioAmber Announces Richard Eno CEO
Benzinga
Tuesday, August 08, 2017
Mid-Afternoon Market Update: Michael Kors Gains On Earnings Beat; Commercial Vehicle Shares Slide
Benzinga
22 Biggest Mid-Day Losers For Tuesday
Benzinga
Mid-Day Market Update: Stocks Turn Higher; Depomed Shares Plummet
Benzinga
BioAmber Reports $11M Offering Of Common Stoc...
Benzinga
25 Stocks Moving In Tuesday's Pre-Market Session
Benzinga
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch